We use cookies to give you the best online experience. By clicking "Accept Cookies" or continuing to browse our website, you agree to allow cookies to be placed. To find out more, visit our Privacy Policy.

Browse by category
Alzheimer's Disease Testing

pTau Testing for Alzheimer’s Risk: What It Is, Why It Matters, and How Aviv Clinics Can Help

Alzheimer's Disease Testing
June 25, 2025

As the years progress, it’s common for us to become more aware of occasional memory lapses or moments of forgetfulness. But when do these minor gaffes become a cause for concern? At Aviv Clinics, we believe in the power of proactive aging,  and we’re proud to introduce walk-in pTau-217 testing for Alzheimer’s risk to our many brain health offerings.  This groundbreaking blood test can help assess your risk for developing Alzheimer’s disease, even before symptoms appear.

With Alzheimer’s disease affecting nearly 7 million people in the United States alone, you may be curious if pTau testing is right for you.  Here’s what you need to know about pTau testing at Aviv Clinics, and how it can fit into a comprehensive plan to protect your brain health.


What Is pTau?

Phosphorylated tau, or pTau, is a protein found in the brain. In healthy brains, tau proteins can help stabilize the structure of neurons, or nerve cells. But in the early stages of Alzheimer’s disease, tau becomes abnormally phosphorylated, forming tangles that disrupt communication between brain cells.

Although pTau isn’t considered a direct cause of Alzheimer’s disease, high levels of pTau in the blood are now recognized as one of the most accurate indicators of early Alzheimer’s disease.  Elevated pTau levels are correlated with brain atrophy, cognitive decline, and accumulation of amyloid plaques.

Importantly, the presence of elevated pTau does not confirm a diagnosis of Alzheimer’s but suggests an increased likelihood of associated brain changes.

Why Aviv Clinics Offers pTau Testing

Until very recently, detecting Alzheimer’s pathology in the brain required invasive spinal taps or expensive PET scans. The recent development of blood-based biomarkers like pTau has transformed early detection, offering a faster, simpler, and more accessible path to answers.

While pTau-217 testing is not yet FDA-approved as a standalone diagnostic tool, emerging research shows its strong potential to aid in early risk assessment for Alzheimer’s-related pathology. At Aviv Clinics, we offer this test as part of a broader approach to brain health for individuals interested in gaining early insights, especially those with risk factors or mild cognitive symptoms.

Research published in January 2024 noted that commercially available pTau-217 testing showed “high diagnostic accuracy.” In their analysis, pTau tests outperformed all other blood-based biomarkers in predicting amyloid and tau status.


How Accurate Is the pTau Test Compared to Other Alzheimer’s Tests?

pTau Blood Testing for Alzheimers

The pTau blood test offers comparable accuracy to other tests available. Additionally, tests that measure pTau provide an early glimpse into changes in the brain that may be happening silently.

Although traditional cognitive screening tests can reveal signs of dementia or Alzheimer’s disease, these are typically not performed until a patient begins to experience preliminary symptoms. However, our bodies can show elevated levels of pTau-217 more than 20 years prior to the onset of Alzheimer’s disease symptoms.

The pTau blood test has comparable accuracy to spinal fluid analysis and PET scans. Unlike these complex tests, however, it only requires a simple blood draw to perform.

Despite these strengths, it is important to recognize that no test is perfect. Conditions like chronic kidney disease, stroke, and myocardial infarction can also increase pTau levels, potentially leading to false-positive results. For those with high pTau levels, further evaluation and testing are required to confirm their source.

While early results are encouraging, clinical interpretation should always be done in context and in consultation with a trained healthcare professional. At Aviv Clinics, our physicians will carefully review your pTau results with you, provide clear answers, and tailor any recommended follow-up to your specific needs.


Who Should Consider a Walk-in pTau Test?

The pTau-217 test is ideal for individuals who meet one or more of these criteria:

This test is not currently approved as a screening tool for the general population and should be interpreted as part of a larger clinical picture.

 

 

What to Expect When You Get a pTau Test at Aviv Clinics

Aviv Clinics Pre Testing for pTau

The process of pTau testing at Aviv Clinics is simple:

  1. Pre-Testing:  You don’t require an appointment or have to fast before pTau testing at Aviv. However, as with many blood tests, you should not take biotin supplements for a minimum of three days before your blood draw. If you take a daily multivitamin, please check its ingredients to determine if it contains biotin.
  2. Blood Draw:  A simple blood sample is taken during your walk-in testing visit at our clinic at The Center for Advanced Healthcare in The Villages®.
  3. Analysis:  Your sample is sent to a certified laboratory and tested for pTau levels.
  4. Results: After approximately 10 days, one of our board-certified physicians will review your test results with you and discuss and what steps, including lifestyle interventions, you can take next to preserve your brain health.

What Happens After You Get Your pTau Results?

Our physicians will evaluate your results in the context of your full medical history. Depending on your results, they may recommend further imaging or cognitive testing when indicated.

Your results are just the beginning. Whether your pTau levels are elevated or normal, we’ll help you:

  • Understand your current brain health profile
  • Identify lifestyle risk factors
  • Determine whether additional assessments are appropriate for a more in-depth evaluation
  • Explore personalized interventions, including the Aviv Medical Program, which can be tailored to address your cognitive performance.

Why Early Detection Matters: The Aviv Clinics Approach

Illustration of Alzheimers Brain as Puzzle with missing pieces

Blood-based biomarkers like pTau are the next frontier in Alzheimer’s research and prevention. Aviv Clinics is proud to be part of this future by offering cutting-edge tools that empower individuals to take charge of their brain health.

The earlier you understand your cognitive health, and the more options you have for both prevention and treatment. If testing reveals that your pTau levels are elevated, you may be a candidate for more advanced cognitive assessments, targeted brain health therapies, or ongoing monitoring to track changes over time. You may consider lifestyle modifications like dietary changes, physical activity, and stress management. These factors, and others, can have a direct impact on your brain health.

For those looking to take a more proactive approach, Aviv Clinics offers comprehensive, personalized programs designed to enhance brain performance. Our clinical team will create a custom Aviv Medical Program based on your test results, physiology, medical history, and personal goals. Your tailored plan may include a combination of evidence-based interventions such as:

If testing reveals that your pTau levels are within normal range, you’ll have a valuable baseline to compare against in the future.

Either way, this test allows you to take charge of your cognitive health today — when you can work towards making a meaningful difference. Early identification of at-risk individuals, particularly those with mild symptoms or risk factors, can help tailor effective interventions.

At Aviv Clinics, pTau testing is used as part of an integrative approach rather than a standalone diagnosis.


Is pTau Testing Covered by Insurance?

At this time, pTau-217 testing is not covered by Medicare, Medicaid, or private insurance. This means the cost of these tests is typically out-of-pocket. However, patients with a Health Savings Account (HSA) or Flexible Spending Account (FSA) may be covered if deemed medically necessary. If you have an HSA or FSA, we recommend you contact your plan administrator and inquire about coverage.

How Much Does pTau Testing Cost?

Aviv Clinics offers pTau-217 testing for $350 on a walk-in basis, making this advanced biomarker test both accessible and affordable. Unlike testing conducted at clinical laboratory services, this cost also includes physician interpretation of your results.

When certain conditions apply, pTau testing may qualify as a tax-deductible expense in the United States. Consult your tax advisor for more information about deductible medical expenses.

Are you interested in pTau testing as part of a broader evaluation of your cognitive health?  Contact our team for details.


Take the Next Step

If you’re an older adult and starting to think more seriously about your brain health, you’re not alone. Fortunately, with cutting-edge tools like pTau testing, Aviv Clinics empowers you to take control of your cognitive health, now and in the future.

Whether you’re concerned about memory changes, have a family history of Alzheimer’s, or want a clearer picture of your brain health, our team is here to help.

Call Aviv Clinics at 352-492-6634 or reach out through our contact form to learn more, or stop by our clinic in The Villages between 8:00 AM and 4:00 PM, Monday through Friday for your walk-in pTau blood test.

Your brain deserves a proactive plan. Aviv Clinics is ready to help you build it.

Skip to content